4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 615.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,250.00p
  • 52 Week Low: 606.00p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 767
  • Market Cap: £95.56m

Latest Deals

Traded Action Notifier PriceAmountValue
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
29-Sep-25 Buy Heikki Lanckriet 749.00p 2,000 £14,980.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,119,688 £6,886,081
Amy Walker 44,016 £270,698
Hansjörg Plaggemars 6,667 £41,002

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £31,486,420
DELPHI Unternehmensberatung AG 5,119,743 £31,486,420
4bb AG 5,115,852 £31,462,490
M&G Plc 4,627,741 £28,460,607
Elevage Medical Technologies Holdings 4,627,741 £28,460,607
Deutsche Balaton AG 4,432,637 £27,260,718
2invest AG 2,229,083 £13,708,860
Sparta AG 1,351,718 £8,313,066
Latonba AG 778,891 £4,790,180
Franciscus De Busschere 537,255 £3,304,118

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 615.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,250.00p
52 Week Low 606.00p
Volume 767
Shares Issued 15.54m
Market Cap £95.56m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average12.20% above the sector average
Price Trend
34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average34.27% below the market average
4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average4.55% above the sector average
Income Not Available
Growth
59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average59.11% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 05-Jan-2026

Time Volume / Share Price
13:47 747 @ 606.00p
08:49 20 @ 606.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page